RxDoctor Payments DataLook up a doctor →

Roger McKinney, MD

Family Medicine · Lebanon, TNNPI 1215995972

Payments from drug & device makers

$18,078in general payments, 2019–2025

Across 975 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AstraZeneca$2K
  • GSK$1K
  • Boston Scientific$1K
  • Amgen$975
  • AbbVie$966
  • plus $8K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk174$3,133
AstraZeneca(2 entities)73$2,144
GSK81$1,420
Boston Scientific14$1,039
Amgen59$975
AbbVie(2 entities)92$966
Boehringer Ingelheim61$924
Lilly USA, LLC49$721
Astellas Pharma US Inc33$657
Johnson & Johnson30$570
Pfizer38$556
Corcept Therapeutics10$324
Teva Pharmaceuticals USA, Inc.24$317
Xeris Pharmaceuticals, Inc.21$313
Sunovion Pharmaceuticals Inc.15$302
Sumitomo Pharma America, Inc.10$265
Sanofi-aventis U.S. LLC20$262
Novartis16$261
Esperion Therapeutics, Inc.10$261
Otsuka America Pharmaceutical, Inc.13$252
Bayer10$226
Eisai Inc.14$209
Amarin Pharma, Inc.11$204
Exact Sciences12$178
Inspire Medical Systems, Inc.3$153
Vanda Pharmaceuticals Inc.2$120
Abbott7$120
Genentech USA, Inc.6$95
Biohaven Pharmaceutical Holding Company Ltd.4$93
Aimmune Therapeutics, Inc.5$87
Avanir Pharmaceuticals, Inc.4$69
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$63
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$63
Phathom Pharmaceuticals, Inc.3$61
Nestle Healthcare Nutrition Inc.3$61
Lundbeck LLC3$48
E.r. Squibb & Sons, L.L.C.4$47
Almatica Pharma LLC3$44
Kowa Pharmaceuticals America, Inc.3$37
Radius Health, Inc.3$37
Neurocrine Biosciences, Inc.2$37
Merck3$36
Seqirus USA Inc2$29
Medtronic2$28
Cranial Technologies, Inc2$27
Ultragenyx Pharmaceutical Inc.2$24
Sanofi Pasteur Inc.1$23
Axsome Therapeutics, Inc.1$21
Sun Pharmaceutical Industries Inc.1$20
Verrica Pharmaceuticals Inc.1$19
Idorsia Pharmaceuticals US Inc1$18
Antares Pharma, Inc.1$18
Lifescan, Inc.1$17
Dexcom, Inc.1$17
Cequr Corporation1$16
Azurity Pharmaceuticals, Inc.1$16
Daiichi Sankyo Inc.1$15
Acadia Pharmaceuticals Inc1$12
Bardy Diagnostics, Inc.1$8

How this compares

$18,078 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$147,554
Medicare patients
275
Services billed
2,975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Lebanon

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →